ETCM
CLBT icon

Evolutionary Tree Capital Management’s Cellebrite CLBT Stock Holding History

Evolutionary Tree Capital Management’s Portfolio CLBT Stock Details CLBT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.22M Sell
152,051
-31,422
-17% -$415K 4.19% 7
2026
Q1 		$2.53M Buy
183,473
+33,829
+23% +$510K 4.75% 8
2025
Q4 		$2.7M Buy
149,644
+134,644
+898% +$2.42M 3.13% 15
2025
Q3 		$278K Buy
+15,000
New +$236K 0.3% 28

Other funds holding CLBT

TWCM
True Wind Capital Management San Francisco, California $226M AUM 2.79% 1-Year Est. Return
VC
Voss Capital Houston, Texas $2.15B AUM 33.46% 1-Year Est. Return
PP
Pertento Partners London, United Kingdom $1.86B AUM 53.86% 1-Year Est. Return
PF
Phoenix Financial Givatayim, Israel $14.6B AUM 57.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
NTCM
Nine Ten Capital Management Chicago, Illinois $321M AUM 44.58% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
CI
Clal Insurance Tel-Aviv, Israel $22.3B AUM 79.91% 1-Year Est. Return

Evolutionary Tree Capital Management's CLBT Position: Q2 2026 in Review

Evolutionary Tree Capital Management reduced its Cellebrite (CLBT) stake by 17% in Q2 2026, selling an estimated $415K and leaving 152,051 shares worth $2.22M. The position accounts for 4.19% of the portfolio, ranked #7.

Evolutionary Tree Capital Management first reported a position in CLBT in Q3 2025 and has held it in 4 quarters since. The position peaked at $2.7M in Q4 2025. 200 funds tracked by Wall St. Rank hold CLBT as of Q2 2026.

  • Evolutionary Tree Capital Management held 152,051 shares of Cellebrite worth $2.22M as of Q2 2026.
  • Evolutionary Tree Capital Management sold 31,422 Cellebrite shares in Q2 2026, an estimated $415K.
  • Cellebrite made up 4.19% of Evolutionary Tree Capital Management's portfolio in Q2 2026, its #7 holding.
  • Evolutionary Tree Capital Management first reported a position in Cellebrite in Q3 2025 and has held it in 4 quarters since.
  • Evolutionary Tree Capital Management's Cellebrite position peaked at $2.7M in Q4 2025.
  • 200 funds tracked by Wall St. Rank held Cellebrite as of Q2 2026.

Based on Evolutionary Tree Capital Management's 13F filing for Q2 2026, filed 13 Aug 2026.